Jong Hun Kim
Physician in Salt Lake City, UT
License number
Utah 8026014-1205
Issued Date
Jun 27, 2011
Expiration Date
Jan 31, 2016
Category
Physician
Type
Physician & Surgeon
Address
Address
Salt Lake City, UT
Education
ECFMG, Feb 25, 2002
Professional information
Jong Hun Kim, Salt Lake City UT
Specialties:
Infectious Disease Specialist
Address:
50 N Medical Dr, Salt Lake City, UT 84132
30 N 1900 E, Salt Lake City, UT 84132
30 N 1900 E, Salt Lake City, UT 84132
Dr. Jong H Kim - MD (Doctor of Medicine)
Hospitals:
30 N 1900 E, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
U OF U/ DEPT. OF ANESTHESIOLOGY
30 N 1900 E, Salt Lake City 84132
UNIV OF UT, SCH OF MED
30 N 1900 E SUITE 43319, Salt Lake City 84132
30 N 1900 E, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
U OF U/ DEPT. OF ANESTHESIOLOGY
30 N 1900 E, Salt Lake City 84132
UNIV OF UT, SCH OF MED
30 N 1900 E SUITE 43319, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
U OF U/ DEPT. OF ANESTHESIOLOGY
30 N 1900 E, Salt Lake City 84132
UNIV OF UT, SCH OF MED
30 N 1900 E SUITE 43319, Salt Lake City 84132
30 N 1900 E, Salt Lake City 84132
50 N Medical Dr, Salt Lake City 84132
U OF U/ DEPT. OF ANESTHESIOLOGY
30 N 1900 E, Salt Lake City 84132
UNIV OF UT, SCH OF MED
30 N 1900 E SUITE 43319, Salt Lake City 84132
Stabilization And Controlled Delivery Of Ionic Biopharmaceuticals
US Patent:
2005011, Jun 2, 2005
Filed:
Sep 22, 2004
Appl. No.:
10/948077
Inventors:
You Bae - Salt Lake City UT, US
Jong Kim - Salt Lake City UT, US
Ajay Taluja - Salt Lake City UT, US
Jong Kim - Salt Lake City UT, US
Ajay Taluja - Salt Lake City UT, US
International Classification:
C12N015/88, C07H021/04, C07K014/47
US Classification:
435458000, 530350000, 536023200, 525054100, 525054200
Abstract:
Compositions and methods for stabilization and controlled release of ionic biopharmaceuticals are disclosed. Illustrative compositions according to the present invention include polyelectrolyte-PEG diblock copolymers complexed by ionic bonds with the ionic biopharmaceuticals. Additional illustrative compositions include microspheres encapsulating polyelectrolyte-PEG diblock copolymers complexed by ionic bonds with the ionic biopharmaceuticals. A method of delivering a biopharmaceutical to a person in need thereof involves administering microspheres that encapsulate biopharmaceutical/polyelectrolyte-PEG diblock copolymer complexes.